Multiple financial institutions, including Barclays and Goldman Sachs, issued positive ratings and target price increases for LifeStance Health Group.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Multiple financial institutions, including Barclays and Goldman Sachs, issued positive ratings and target price increases for LifeStance Health Group.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- MarketBeat reports on the stock rating for Diversified Healthcare Trust, which is listed on Nasdaq, following a target price raise by Royal Bank of Canada.
- Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
- Cisco stock is traded on Nasdaq, with multiple firms issuing rating changes and MarketBeat reporting consensus.
- EyePoint Pharmaceuticals was listed on Nasdaq, accompanied by rating updates from TD Cowen (downgrade) and Jefferies (upgrade).